BioCentury
ARTICLE | Company News

Amorfix, QPS Holdings deal

February 4, 2013 8:00 AM UTC

Amorfix and QPS partnered to develop Amorfix's EP-AD Diagnostic CSF Test for use as both an early stage diagnostic for Alzheimer's disease and as a biomarker to facilitate AD drug development. The ul...